• No results found

Characteristics of Sotos syndrome Boer, L. de

N/A
N/A
Protected

Academic year: 2021

Share "Characteristics of Sotos syndrome Boer, L. de"

Copied!
7
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

Characteristics of Sotos syndrome

Boer, L. de

Citation

Boer, L. de. (2005, April 28). Characteristics of Sotos syndrome. Retrieved from https://hdl.handle.net/1887/4565

Version: Corrected Publisher’s Version

License: Licence agreement concerning inclusion of doctoral thesis in theInstitutional Repository of the University of Leiden Downloaded from: https://hdl.handle.net/1887/4565

(2)

CHAPTER 5

$X[RORJLFDOGDWDLQSDWLHQWVFOLQLFDOO\VXVSHFWHGRI

6RWRVV\QGURPHZLWK16'JHQHDOWHUDWLRQV



L. de Boer1, S. le Cessie2, J.M. Wit1

Department of Paediatrics1, Department of Medical Statistics2, Leiden University Medical Center, Leiden, the Netherlands

(3)
(4)

$EVWUDFW

$LP

Nuclear receptor binding SET domain containing protein 1 (NSD1) gene mutations and deletions (NSD1+/-) are the major cause of Sotos syndrome. The aim was to investigate which auxology parameters relate to NSD1+/- in patients clinically suspected of Sotos

syndrome. 0HWKRGV

In 32 patients clinically suspected of Sotos syndrome, we compared auxology parameters between NSD1+/- patients and patients without NSD1 gene alterations (NSD1+/+). The statistical performance of these parameters to predict NSD1+/- was assessed.

5HVXOWV

Arm span for height standard deviation score (SDS) and hand length SDS were significantly higher in NSD1+/- patients.

&RQFOXVLRQ

Arm span for height and hand length are discriminating parameters between NSD1 +/-and NSD1+/+.

Sotos syndrome is an overgrowth syndrome, characterised by macrocephaly, advanced bone age, developmental delay and typical facial features as frontal bossing, pointed chin, high hair line, antimongoloid slant of palpebral fissures, dolichocephaly and a high palate (1, 2). In 2002 NSD1 gene alterations were discovered as the major cause of Sotos syndrome (3). According to earlier reports, auxological measures as arm span, hand length and foot length are increased in Sotos syndrome (2, 4), hand and foot length were even large when corrected for height (2), and upper to lower segment body ratios are decreased (4). These auxological measurements have not yet been related to NSD1 gene alterations.

(5)

92

Table 1. Auxology data (SDS) of patients with and without NSD1 gene alterations, mean (95% CI)

NSD+/+ NSD+/- t-test

Number of patients (number < 15 years) 19 (15) 13 (7) Age Mean (range) in years 14.1 (1.8-48.4) 13.3 (2.1-36.3)

Sex Male/Female 14/5 8/5

Birth parameters length 0.8 (0.2-1.4) 1.4 (0.2-2.5) 0.32 for gestational age weight 0.2 (-0.4-0.8) 0.3 (-0.6-1.3) 0.78 head circumference 1.0 (0.3-1.7) 1.2 (0.2-2.1) 0.78

Height Height for age 1.4 (0.7-2.1) 1.9 (1.1-2.6) 0.40 only patients < 15 years 1.8 (1.3-2.4) 2.4 (1.0-3.8) 0.32 Height – target height 0.9 (0.3-1.6) 1.8 (1.1-2.5) 0.06 only patients < 15 years 1.1 (0.4-1.7) 2.0 (0.9-3.2) 0.10

Sitting height and Sitting height for age 1.4 (0.5-2.2) 1.0 (0.3-1.7) 0.49 leg length Leg length for age 1.6 (1.2-2.1) 1.9 (1.2-2.6) 0.46 Sitting height/height -0.9 (-1.6--0.2) -1.0 (-1.6--0.4) 0.91

Arm span Arm span for age 1.0 (0.2-1.8) 2.0 (1.3-2.6) 0.09 Arm span for height -0.3 (-1.0-0.5) 1.6 (0.2-3.1) 

Hand and foot Hand length for age 0.8 (0.1-1.7) 2.3 (1.5-3.1)  length Foot length for age 0.7 (-0.3-1.6) 2.1 (0.8-3.4) 0.06 Foot length for height -1.2 (-2.3--0.1) 0.4 (-1.3-2.0) 0.09

Head

circumference Head circumference for age 2.2 (1.5-2.8) 2.6 (1.9-3.4) 0.32

BMI 1.0 (0.2-1.7) 1.0 (0.1-1.9) 0.98

NSD1+/+ = no NSD1 gene alteration

NSD1+/- = NSD1 gene mutation or deletion

CI = confidence interval

(6)

Table 2. Statistical characteristics of four auxology parameters at optimal cut-off limits for discriminating between patients with and without NSD1 gene alteration

Hand length SDS Arm span for Height

SDS Height-target height SDS Patients < 15 yrs Head circumference SDS AUC 0.737 0.732 0.705 0.632 Optimal cut-off limit > 1.5 SDS > 0.25 SDS > 2 SDS > 2 SDS Sensitivity 0.85 0.73 0.57 0.77 Specificity 0.72 0.72 0.87 0.63 + LR (95%CI) 3.05 (1.40-6.65) 2.62 (1.14-5.99) 4.29 (1.01-18) 2.09 (1.08-4.04) PPV (95%CI) 0.69 (0.50-0.83) 0.62 (0.41-0.79) 0.67 (0.32-0.89) 0.59 (0.42-0.73) - LR (95% CI) 0.21 (0.06-0.79) 0.38 (0.14-1.03) 0.49 (0.21-1.19) 0.37 (0.13-1.04) NPV (95%CI) 0.87 (0.64-0.96) 0.81 (0.61-0.92) 0.81 (0.64-0.91) 0.80 (0.58-0.92)

AUC=area under the curve, CI= confidence interval, +LR= Likelihood ratio for a positive test result, PPV= positive predictive value, -LR= Likelihood ratio for a negative test result, NPV= negative predictive value

length), > 2.0 SDS (height - TH, patients < 15 yrs) and > 2.1 SDS (head circumference). The rounded values are shown in table 2. Hand length SDS and arm span for height SDS combined (using results of logistic regression) in a ROC curve yield an AUC of 0.840. All four parameters showed a significantly elevated positive likelihood ratio. Hand length showed a significantly decreased negative likelihood ratio.

In all patients suspected of Sotos syndrome (NSD1+/+ and NSD1+/- patients), the results show an increased mean arm span and, as described before (2), increased hand length. Foot length corrected for height was not significantly elevated in both subgroups. In agreement with another study (4), decreased sitting height/height ratios were found, which means leg length contributes most to the increased height. If both subgroups are compared, arm span in NSD1+/- patients is disproportional, meaning that after height correction still an increased value is found, in contrast to the findings in NSD1+/+ patients. Hand length above 1.5 SDS is a good discriminating parameter for NSD1+/-. No significant differences were found between the two groups for the sitting height/height ratio.

(7)

94

$FNQRZOHGJHPHQWV



Thanks are due to Liselore van Esch for assisting in collection of the data.

5HIHUHQFHV

1. Sotos JF, Dodge PR, Muirhead D, Crawford JD, Talbot NB: Cerebral gigantism

in childhood. A syndrome of excessively rapid growth with acromegalic features and a nonprogressive neurologic disorder. N Engl J Med 1964; 271:109-116

2. Cole TR, Hughes HE: Sotos syndrome: a study of the diagnostic criteria and

natural history. J Med Genet 1994; 31(1):20-32

3. Kurotaki N, Imaizumi K, Harada N, Masuno M, Kondoh T, Nagai T:

Haploinsufficiency of NSD1 causes Sotos syndrome. Nat Genet 2003; 30:365-366

4. Agwu JC, Shaw NJ, Kirk J, Chapman S, Ravine D, Cole TR: Growth in Sotos

syndrome. Arch Dis Child 1999; 80(4):339-342

5. Fredriks AM, van Buuren S, Burgmeijer RJ, Meulmeester JF, Beuker RJ,

Brugman E et al: Continuing positive secular growth change in The Netherlands 1955-1997. Pediatr Res 2000; 47(3):316-323

6. Fredriks AM, van Buuren S, Wit JM, Verloove-Vanhorick SP: Body index

measurements in 1996-7 compared with 1980. Arch Dis Child 2000; 82(2):107-112

7. Gerver WJM, de Bruin R: Paediatric Morphometrics, A Reference Manual.

Utrecht: Wetenschappelijke uitgeverij Bunge, 1996

8. Niklasson A, Ericson A, Fryer JG, Karlberg J, Lawrence C, Karlberg P: An

update of the Swedish reference standards for weight, length and head circumference at birth for given gestational age (1977-1981). Acta Paediatr Scand 1991; 80(8-9):756-762

Referenties

GERELATEERDE DOCUMENTEN

No parts of this publication may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopy, recording, or any in- formation storage

In accordance with this, other reports of patients with gene alterations leading to an opposite growth phenotype have emerged recently, for example a missense mutation of the

A recent study did not detect any sequence abnormalities or epigenetic changes of the NSD1 promoter region in a group of 18 classical Sotos syndrome patients without any

We also studied the SoS proximal and distal LCRs (PLCR and DLCR, respectively) in detail, by computational analysis using the published May 2004 human genome sequence,

Secondly, BRWD3 is another gene possibly related to our patient’s phenotype, because loss of function mutations were identified in 4 male patients with X-linked mental retardation,

Third, NSD1 was shown to influence many genes involved in the MAPK pathway (Figure 2 A and B) and the net effect of these changes might be more important for the MAPK/ERK

In 2002 werd aangevangen met het niet academische gedeelte van de opleiding kindergeneeskunde voor anderhalf jaar in het Jeroen Bosch ziekenhuis te Den Bosch

Geconcludeerd kan worden dat de patienten uit deze studie met een klinische verdenking op Sotos syndroom met een NSD1 genafwijking onderscheiden kunnen worden